{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T05:28:26Z","timestamp":1787635706112,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier","isbn-type":[{"value":"9780443235306","type":"print"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/bs.pmbts.2024.05.003","type":"book-chapter","created":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T13:15:48Z","timestamp":1719580548000},"page":"117-128","source":"Crossref","is-referenced-by-count":1,"title":["Peptide pharmacology: Pioneering interventions for alcohol use disorder"],"prefix":"10.1016","author":[{"given":"Ramkumar","family":"Katturajan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Evan Prince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abilash","family":"Valsala Gopalakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/bs.pmbts.2024.05.003_bib1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/0974150X231173472","article-title":"Pattern of alcohol use and problems associated with alcohol use among patients with alcohol use disorder: an exploratory study","volume":"19","author":"Das","year":"2023","journal-title":"Nurs Midwifery Res J"},{"key":"10.1016\/bs.pmbts.2024.05.003_bib2","doi-asserted-by":"crossref","unstructured":"A. Nadkarni\u00a0et al. Alcohol use among adolescents in India: a systematic review Glob Ment Health (Camb) 9 1\u221225 https:\/\/doi.org\/10.1017\/gmh.2021.48.","DOI":"10.1017\/gmh.2021.48"},{"key":"10.1016\/bs.pmbts.2024.05.003_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fncir.2023.1218737","article-title":"GABAergic signaling in alcohol use disorder and withdrawal: pathological involvement and therapeutic potential","volume":"17","author":"Dharavath","year":"2023","journal-title":"Front Neural Circuits"},{"issue":"10","key":"10.1016\/bs.pmbts.2024.05.003_bib4","first-page":"48","article-title":"An overview of pharmacotherapy options for alcohol use disorder","volume":"35","author":"Carpenter","year":"2018","journal-title":"Fed Pract"},{"key":"10.1016\/bs.pmbts.2024.05.003_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109374","article-title":"Role of the mesolimbic dopamine pathway in the antidepressant effects of ketamine","volume":"225","author":"Cardona-Acosta","year":"2023","journal-title":"Neuropharmacology"},{"issue":"11","key":"10.1016\/bs.pmbts.2024.05.003_bib6","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/nrn3119","article-title":"Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications","volume":"12","author":"Goldstein","year":"2011","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/bs.pmbts.2024.05.003_bib7","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fnsys.2019.00028","article-title":"Dorsal striatal circuits for habits, compulsions and addictions","volume":"13","author":"Lipton","year":"2019","journal-title":"Front Syst Neurosci"},{"issue":"4","key":"10.1016\/bs.pmbts.2024.05.003_bib8","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1152\/physrev.00014.2018","article-title":"The neuroscience of drug reward and addiction","volume":"99","author":"Volkow","year":"2019","journal-title":"Physiological Rev"},{"key":"10.1016\/bs.pmbts.2024.05.003_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.654931","article-title":"The biology and pathobiology of glutamatergic, cholinergic, and dopaminergic signaling in the aging brain","volume":"13","author":"Gasiorowska","year":"2021","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/bs.pmbts.2024.05.003_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fncir.2022.867053","article-title":"Anatomy and function of ventral tegmental area glutamate neurons","volume":"16","author":"Cai","year":"2022","journal-title":"Front Neural Circuits"},{"issue":"11","key":"10.1016\/bs.pmbts.2024.05.003_bib11","first-page":"1468","article-title":"Happiness & health: the biological factors- systematic review article","volume":"43","author":"Dfarhud","year":"2014","journal-title":"Iran J Public Health"},{"issue":"3","key":"10.1016\/bs.pmbts.2024.05.003_bib12","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.3390\/ijms23031445","article-title":"Bioactive peptides: synthesis, sources, applications, and proposed mechanisms of action","volume":"23","author":"Akbarian","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/bs.pmbts.2024.05.003_bib13","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.3390\/pharmaceutics15061648","article-title":"Targeting peptides: the new generation of targeted drug delivery systems","volume":"15","author":"Todaro","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/bs.pmbts.2024.05.003_bib14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neubiorev.2018.09.010","article-title":"Dopamine and opioid systems adaptation in alcoholism revisited: convergent evidence from positron emission tomography and postmortem studies","volume":"106","author":"Hansson","year":"2019","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/bs.pmbts.2024.05.003_bib15","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/164_2017_86","article-title":"Corticotropin-releasing factor (CRF) neurocircuitry and neuropharmacology in alcohol drinking","volume":"248","author":"Schreiber","year":"2018","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/bs.pmbts.2024.05.003_bib16","first-page":"177","article-title":"Chapter seven\u2014The role of neuropeptide Y (NPY) in alcohol and drug abuse disorders, in International Review of Neurobiology","volume":"136","author":"Robinson","year":"2017"},{"key":"10.1016\/bs.pmbts.2024.05.003_bib17","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.pneurobio.2018.10.001","article-title":"Role of glutamatergic system and mesocorticolimbic circuits in alcohol dependence","volume":"171","author":"Alasmari","year":"2018","journal-title":"Prog Neurobiol"},{"key":"10.1016\/bs.pmbts.2024.05.003_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fnsys.2022.1014768","article-title":"Endogenous opioid systems alterations in pain and opioid use disorder","volume":"16","author":"Higginbotham","year":"2022","journal-title":"Front Syst Neurosci"},{"key":"10.1016\/bs.pmbts.2024.05.003_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fnsys.2022.932546","article-title":"The role of enkephalinergic systems in substance use disorders","volume":"16","author":"Rysztak","year":"2022","journal-title":"Front Syst Neurosci"},{"issue":"3","key":"10.1016\/bs.pmbts.2024.05.003_bib20","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s40265-021-01670-3","article-title":"Novel agents for the pharmacological treatment of alcohol use disorder","volume":"82","author":"Burnette","year":"2022","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/bs.pmbts.2024.05.003_bib21","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/acer.14264","article-title":"Possible role of CRF-Hcrt interaction in the infralimbic cortex in the emergence and maintenance of compulsive alcohol-seeking behavior","volume":"44","author":"Kim","year":"2020","journal-title":"Alcohol Clin Exp Res"},{"issue":"12","key":"10.1016\/bs.pmbts.2024.05.003_bib22","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1111\/acer.13507","article-title":"The corticotropin releasing factor receptor 1 in alcohol use disorder: still a valid drug target?","volume":"41","author":"Pomrenze","year":"2017","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/bs.pmbts.2024.05.003_bib23","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3389\/fendo.2017.00178","article-title":"Neuropeptide Y in alcohol addiction and affective disorders","volume":"8","author":"Thorsell","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/bs.pmbts.2024.05.003_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.737440","article-title":"Meta-analysis on the association of neuropeptide Y rs16139 variant with the risk of alcoholism","volume":"12","author":"Chen","year":"2021","journal-title":"Front Psychiatry"},{"issue":"8","key":"10.1016\/bs.pmbts.2024.05.003_bib25","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s00702-014-1180-8","article-title":"Glutamate as a neurotransmitter in the healthy brain","volume":"121","author":"Zhou","year":"2014","journal-title":"J Neural Transm (Vienna)"},{"issue":"4","key":"10.1016\/bs.pmbts.2024.05.003_bib26","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.3233\/JAD-201146","article-title":"Metabotropic glutamate receptors in Alzheimer\u2019s disease synaptic dysfunction: therapeutic opportunities and hope for the future","volume":"78","author":"Srivastava","year":"2020","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10.1016\/bs.pmbts.2024.05.003_bib27","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13024-023-00675-8","article-title":"Peptide-based approaches to directly target alpha-synuclein in Parkinson\u2019s disease","volume":"18","author":"Allen","year":"2023","journal-title":"Mol Neurodegener"}],"container-title":["Progress in Molecular Biology and Translational Science","Protein and Peptide Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117324001340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117324001340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T05:16:53Z","timestamp":1742620613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877117324001340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9780443235306"],"references-count":27,"URL":"https:\/\/doi.org\/10.1016\/bs.pmbts.2024.05.003","relation":{},"ISSN":["1877-1173"],"issn-type":[{"value":"1877-1173","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}